A major new study has found that transcranial magnetic stimulation (TMS), which applies magnetic energy to the brain, can be ...
Abbott’s neuromodulation systems can significantly reduce pain-related healthcare visits for people living with chronic pain, according to five-year data.
Abbott Park, Illinois Tuesday, January 27, 2026, 13:00 Hrs [IST] ...
Medical Device Network on MSN
Boston Scientific touts long-term data of SCS therapy
At the recently concluded North American Neuromodulation Society annual meeting, Boston presented a total of 17 abstracts.
Abbott Laboratories (NYSE:ABT) Q4 2025 Earnings Call Transcript January 22, 2026 Abbott Laboratories reports earnings inline ...
Abbott Laboratories ( ABT) Q4 2025 Earnings Call January 22, 2026 9:00 AM EST Good morning, and thank you for standing by.
Abbott Laboratories ABT is slated to report fourth-quarter 2025 results on Jan. 22, before the opening bell. The company ...
14d
PainTEQ Announces Appointment of Lalit Venkatesan, PhD as Senior Vice President of Clinical Research
TAMPA, Fla., Jan. 13, 2026 /PRNewswire/ -- PainTEQ, a medical device company dedicated to advancing minimally invasive solutions for sacroiliac (SI) joint dysfunction, today announced the appointment ...
The MarketWatch News Department was not involved in the creation of this content. Real-time insights reveal BIOTRONIK Neuro's remote monitoring with remote programming led to high rates of therapy use ...
Real-time insights reveal BIOTRONIK Neuro's remote monitoring with remote programming led to high rates of therapy use and lower explant rates LAKE OSWEGO, Ore., Jan. 5, 2026 /PRNewswire/ -- A new ...
Background: Refractory angina pectoris represents a significant clinical challenge characterized by persistent chest pain despite maximally tolerated medical therapy and optimal revascularization ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results